1. Home
  2. LQDA vs FCF Comparison

LQDA vs FCF Comparison

Compare LQDA & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • FCF
  • Stock Information
  • Founded
  • LQDA 2004
  • FCF 1934
  • Country
  • LQDA United States
  • FCF United States
  • Employees
  • LQDA N/A
  • FCF N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • FCF Major Banks
  • Sector
  • LQDA Health Care
  • FCF Finance
  • Exchange
  • LQDA Nasdaq
  • FCF Nasdaq
  • Market Cap
  • LQDA 1.7B
  • FCF 1.7B
  • IPO Year
  • LQDA 2018
  • FCF N/A
  • Fundamental
  • Price
  • LQDA $25.95
  • FCF $16.69
  • Analyst Decision
  • LQDA Strong Buy
  • FCF Buy
  • Analyst Count
  • LQDA 10
  • FCF 7
  • Target Price
  • LQDA $31.40
  • FCF $19.00
  • AVG Volume (30 Days)
  • LQDA 3.4M
  • FCF 714.1K
  • Earning Date
  • LQDA 08-12-2025
  • FCF 07-29-2025
  • Dividend Yield
  • LQDA N/A
  • FCF 3.19%
  • EPS Growth
  • LQDA N/A
  • FCF N/A
  • EPS
  • LQDA N/A
  • FCF 1.30
  • Revenue
  • LQDA $19,322,000.00
  • FCF $454,628,000.00
  • Revenue This Year
  • LQDA $190.73
  • FCF $14.59
  • Revenue Next Year
  • LQDA $421.01
  • FCF $8.14
  • P/E Ratio
  • LQDA N/A
  • FCF $13.04
  • Revenue Growth
  • LQDA 30.20
  • FCF N/A
  • 52 Week Low
  • LQDA $8.26
  • FCF $13.54
  • 52 Week High
  • LQDA $26.65
  • FCF $19.96
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 79.56
  • FCF 52.79
  • Support Level
  • LQDA $19.02
  • FCF $16.10
  • Resistance Level
  • LQDA $26.65
  • FCF $17.03
  • Average True Range (ATR)
  • LQDA 1.53
  • FCF 0.35
  • MACD
  • LQDA 0.64
  • FCF 0.03
  • Stochastic Oscillator
  • LQDA 92.88
  • FCF 64.06

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

Share on Social Networks: